ABOUT
Catalina Pharma is a startup pharmaceutical company that is focused on pharmacological treatment of intraoperative hypothermia
NEWS
UA Startup Catalina Pharma Offers New Method to Treat Anesthesia-Induced Hypothermia
A Pharmaceutical Cure for Hypothermia?
U of Arizona start-up repurposes failed pain relief treatment to address surgical hypothermia
TEAM
Amol Patwardhan, MD, PhD
Andrej Romanovsky, MD, PhD
Frank Porreca,
PhD
William Schmidt,
PhD
Secretary, Treasurer and Chief Medical Officer
Amol is a practicing anesthesiologist/pain physician and a pharmacologist with years of experience in TRPV1 pharmacology. He is a PI on funded preclinical and clinical studies.
VP and Chief Scientific Officer-Thermoregulation
Andrej’s lab has discovered the mechanisms of the hypether-mic response to TRPV1 antag-onists. Andrej consulted for 6 big pharma TRP programs. He is the Editor-in-Chief of the journal Temperature
VP and Chief Scientific Officer-Pain
Frank is an internationally recognized preeminent pain pharmacologist with over 500 publications who has served as a consultant to dozens of pharmaceutical companies
President and CEO
Bill is a preclinical and clinical pharmacologist, inventor, and entrepreneur who has worked in pain medicine and anesthesia throughout his career and has helped to bring 6 drugs to the market.